TransIT BrCa Transfection Reagent

22 October 2014

Watch this video to learn more about the TransIT-BrCa Transfection Reagent, the first dedicated breast cancer cell line specific reagent. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental biases.